Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief ...

Key appointment as Opthea progresses the Phase 3 clinical development of OPT-302 in wet AMD

Related Keywords

Australia ,United States ,Melbourne ,Victoria ,Toronto ,Ontario ,Canada ,Israel ,Vancouver ,British Columbia ,Joel Naor ,Megan Baldwin ,Allergan Inc ,Santen Inc ,Development Operations At Kodiak Sciences Inc ,Simon Fraser University ,Nasdaq ,University Of Toronto ,Investment In Biotechnology Companies ,Stem Cells Inc ,Macusight Inc ,Masters Of Business Administration ,Israel Institute Of Technology ,Opthea Limited ,Chief Medical Officer ,Chief Executive Officer ,Managing Director ,Best Corrected Visual Acuity ,Vice President ,Clinical Science ,Development Operations ,Kodiak Sciences ,Global Medical Affairs ,Stem Cells ,Business Administration ,Securities Litigation Reform Act ,Annual Report ,Money ,Ational ,